These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 29865857)

  • 1. Non-natriuretic peptide biomarkers in heart failure with preserved and reduced ejection fraction.
    Oikonomou E; Vogiatzi G; Tsalamandris S; Mourouzis K; Siasos G; Lazaros G; Skotsimara G; Marinos G; Vavuranakis M; Tousoulis D
    Biomark Med; 2018 Jul; 12(7):783-797. PubMed ID: 29865857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial.
    Myhre PL; Vaduganathan M; Claggett BL; Anand IS; Sweitzer NK; Fang JC; O'Meara E; Shah SJ; Desai AS; Lewis EF; Rouleau J; Pitt B; Pfeffer MA; Solomon SD
    JAMA Cardiol; 2018 Oct; 3(10):1000-1005. PubMed ID: 30140899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic Value of Biochemical Markers in Patients With Chronic Heart Failure With Reduced, Borderline and Preserved Left Ventricular Ejection Fraction].
    Bazaeva EV; Myasnikov RP; Metelskaya VA; Boytsov SA
    Kardiologiia; 2017 Mar; 57(3):39-45. PubMed ID: 28762934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers and diagnostics in heart failure.
    Gaggin HK; Januzzi JL
    Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications.
    Tanase DM; Radu S; Al Shurbaji S; Baroi GL; Florida Costea C; Turliuc MD; Ouatu A; Floria M
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31142058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosis marker syndecan-1 and outcome in patients with heart failure with reduced and preserved ejection fraction.
    Tromp J; van der Pol A; Klip IT; de Boer RA; Jaarsma T; van Gilst WH; Voors AA; van Veldhuisen DJ; van der Meer P
    Circ Heart Fail; 2014 May; 7(3):457-62. PubMed ID: 24647119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Biomarkers for the Risk Stratification of Heart Failure with Preserved Ejection Fraction.
    Cypen J; Ahmad T; Testani JM; DeVore AD
    Curr Heart Fail Rep; 2017 Oct; 14(5):434-443. PubMed ID: 28803400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of biomarkers in chronic heart failure with preserved left ventricular ejection fraction].
    Nikiforova TA; Shchekochikhin DY; Kopylov FY; Syrkin AL
    Ter Arkh; 2016; 88(9):102-105. PubMed ID: 28635812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue.
    Valero-Muñoz M; Li S; Wilson RM; Hulsmans M; Aprahamian T; Fuster JJ; Nahrendorf M; Scherer PE; Sam F
    Circ Heart Fail; 2016 Jan; 9(1):e002724. PubMed ID: 26721917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epicardial fat in heart failure patients with mid-range and preserved ejection fraction.
    van Woerden G; Gorter TM; Westenbrink BD; Willems TP; van Veldhuisen DJ; Rienstra M
    Eur J Heart Fail; 2018 Nov; 20(11):1559-1566. PubMed ID: 30070041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of acute heart failure and relevance of biomarkers in elderly patients].
    Ruiz Ortega RA; Manzano L; Montero-Pérez-Barquero M
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():20-5. PubMed ID: 24930079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial.
    Anand IS; Claggett B; Liu J; Shah AM; Rector TS; Shah SJ; Desai AS; O'Meara E; Fleg JL; Pfeffer MA; Pitt B; Solomon SD
    JACC Heart Fail; 2017 Apr; 5(4):241-252. PubMed ID: 28359411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction.
    Tromp J; Khan MAF; Mentz RJ; O'Connor CM; Metra M; Dittrich HC; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JGF; Givertz MM; Bloomfield DM; Van Veldhuisen DJ; Hillege HL; Voors AA; van der Meer P
    JACC Heart Fail; 2017 Jul; 5(7):507-517. PubMed ID: 28624483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited.
    Paulus WJ; Zile MR
    Circ Res; 2021 May; 128(10):1451-1467. PubMed ID: 33983831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.
    Jhund PS; Anand IS; Komajda M; Claggett BL; McKelvie RS; Zile MR; Carson PE; McMurray JJ
    Eur J Heart Fail; 2015 Aug; 17(8):809-17. PubMed ID: 25921853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review.
    Garg A; Virmani D; Agrawal S; Agarwal C; Sharma A; Stefanini G; Kostis JB
    Cardiology; 2017; 136(3):192-203. PubMed ID: 27784010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion.
    Van Aelst LNL; Arrigo M; Placido R; Akiyama E; Girerd N; Zannad F; Manivet P; Rossignol P; Badoz M; Sadoune M; Launay JM; Gayat E; Lam CSP; Cohen-Solal A; Mebazaa A; Seronde MF
    Eur J Heart Fail; 2018 Apr; 20(4):738-747. PubMed ID: 29251818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
    Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.